Skip to main content
. 2021 May 19;188(3):601–613. doi: 10.1007/s10549-021-06238-z

Fig. 2.

Fig. 2

Variation of SMI (a), SMG (b), LBM (c), SMD (d) and muscle cross-sectional area at L3 at three points of the study (baseline, 3 months, 6 months) according to sarcopenic status from the ABLE study (n = 49). ***p < 0.001